Chemical Autophagy Regulators

Adv Exp Med Biol. 2021:1208:289-309. doi: 10.1007/978-981-16-2830-6_13.

Abstract

Autophagy is a catabolic process that removes aggregated proteins and damaged organelles via lysosomal degradation. Increasing evidence suggests that dysfunction of autophagy is associated with a variety of human pathologies, including aging, cancer, neurodegenerative diseases, heart diseases, diabetes, and other metabolic diseases. Current research suggests that the regulation of autophagy may be a novel target for the treatment of these diseases. For this purpose, it is essential to have a deep understanding on the molecular details of autophagy and its regulatory network in each of the disease contexts. Over the years, a variety of chemical autophagy inducers and inhibitors has been developed. The application of these autophagy regulators can assist us in the exploration of the mechanism and therapeutic potential of autophagy regulation. In this chapter, we summarize the recent advances in chemical autophagy regulators to provide methodological support for autophagy research.

MeSH terms

  • Aging
  • Autophagy
  • Humans
  • Lysosomes
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / genetics